Last 70.00 GBp
Change Today 0.00 / 0.00%
Volume 0.0
RXB On Other Exchanges
Symbol
Exchange
London
As of 11:35 AM 01/30/15 All times are local (Market data is delayed by at least 15 minutes).

rex bionics plc (RXB) Snapshot

Open
70.00 GBp
Previous Close
70.00 GBp
Day High
70.00 GBp
Day Low
70.00 GBp
52 Week High
05/8/14 - 182.50 GBp
52 Week Low
12/18/14 - 68.50 GBp
Market Cap
10.0M
Average Volume 10 Days
185.0
EPS TTM
-1.77 GBp
Shares Outstanding
14.3M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for REX BIONICS PLC (RXB)

Related News

No related news articles were found.

rex bionics plc (RXB) Related Businessweek News

No Related Businessweek News Found

rex bionics plc (RXB) Details

Rex Bionics Plc develops and manufactures hands-free robotic exoskeletons for use by wheelchair users in New Zealand. The company offers REX Rehab for use in rehabilitation centers and hospitals; and REX Personal for individual’s specific medical and physical requirements to perform tasks and functions. It sells its products in North America, Europe, and the Asia Pacific. The company was formerly known as Union MedTech plc and changed its name to Rex Bionics Plc in March 2012. Rex Bionics Plc was incorporated in 2007 and is based in North Shore City, New Zealand.

20 Employees
Last Reported Date: 05/2/14
Founded in 2007

rex bionics plc (RXB) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

rex bionics plc (RXB) Key Developments

PhysioFunction Uses Rex Bionics Plc's Technology at Facility of Spinal Cord Injury Charity, Aspire

Rex Bionics plc announced the successful demonstration of Robot Assisted Physiotherapy (RAP), utilising REX technology, by Physiofunction Ltd, at the Aspire Leisure Centre in Stanmore on January 15th. During Robot-Assisted Physiotherapy (RAP), REX lifts patients from a sitting position into a robot-supported standing position, allowing them to take part in a set of supported walking and stretching exercises designed by specialist physiotherapists.

PhysioFunction Launches Physiotherapy Service Using Rex Bionics Plc's Technology

Rex Bionics Plc and PhysioFunction announced the launch by PhysioFunction of the UK's first physiotherapy service using the REX technology for people with mobility impairment PhysioFunction will provide regular out-patient clinics at theChris Moody Centre at Moulton College, Northamptonshire, on a private payer basis; and progressively at PhysioFunction's 14 other neurological physiotherapy facilities in the Midlands, London and Yorkshire. During Robot-Assisted Physiotherapy (RAP), REX lifts patients from a sitting position into a robot-supported standing position, allowing them to take part in a set of supported walking and stretching exercises designed by specialist physiotherapists. Wheelchair users are at risk of developing numerous medical complications from extended periods of sitting. By enabling them to spend more time standing, walking and exercising, REX may offer significant health benefits, including improved cardiovascular performance, maintenance of joint range, and a reduction in infections. PhysioFunction will also act as a Reference Centre for the REX technology, collecting the clinical data which will help to demonstrate the benefits of the technology; and will act as a Test Centre for wheelchair users from the UK and overseas who are considering purchasing or leasing a REX.

Rex Bionics Plc Announces Management Changes

Rex Bionics Plc announce that Crispin Simon has now joined the company as Chief Executive Officer. As announced on 5 August 2014, Jeremy Curnock Cook has also moved to become Deputy Chairman. Crispin Simon has a 25-year track record in industry, predominantly in the commercialization of Medical Technology products. From 2012 to October 2014, Crispin was a full time Director in the UK Government's Department of Business, Innovation and Skills.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
RXB:LN 70.00 GBp 0.00

RXB Competitors

Market data is delayed at least 15 minutes.

Company Last Change
CYBERDYNE Inc ¥3,100 JPY +65.00
Ekso Bionics Holdings Inc $1.40 USD +0.24
Parker-Hannifin Corp $116.46 USD -2.14
ReWalk Robotics Ltd $17.44 USD -0.27
View Industry Companies
 

Industry Analysis

RXB

Industry Average

Valuation RXB Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 2.4x
Price/Book 1.0x
Price/Cash Flow NM Not Meaningful
TEV/Sales 13.0x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact REX BIONICS PLC, please visit www.rexbionics.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.